Bio-Rad to Report Third Quarter 2024 Financial Results on Wednesday, October 30, 2024
15 10월 2024 - 6:30AM
Business Wire
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global
leader in life science research and clinical diagnostics products,
will report its financial results for the third quarter of 2024 on
Wednesday, October 30, 2024, following the close of the market.
Management will discuss these results in a conference call
scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.
To participate, dial 800-579-2543 within the U.S. or
785-424-1789 outside the U.S., access code: BIORAD. A live webcast
of the conference call will also be available in the "Investor
Relations" section of the company’s website under "Events &
Presentations" at investors.bio-rad.com. A replay of the webcast
will be available for up to a year.
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in
developing, manufacturing, and marketing a broad range of products
for the life science research and clinical diagnostics markets.
Based in Hercules, California, Bio-Rad operates a global network of
research, development, manufacturing, and sales operations with
approximately 7,700 employees and $2.7 billion in revenues in 2023.
Our customers include universities, research institutions,
hospitals, food safety and environmental quality laboratories, and
biopharmaceutical companies. Together, we develop innovative,
high-quality products that advance science and save lives. To learn
more, visit bio-rad.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241014119743/en/
Investor Contact: Edward Chung, Investor Relations
510-741-6104 ir@bio-rad.com
Media Contact: Anna Gralinska, Corporate Communications
510-741-6643 cc@bio-rad.com
Bio Rad Laboratories (NYSE:BIO)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024
Bio Rad Laboratories (NYSE:BIO)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024
